Veracyte reported $85.27M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US USD 64.42M 1.07M
Agilent A:US USD 1.38B 71M
Anika Therapeutics ANIK:US USD 28.58M 14.46M
Arrowhead Research ARWR:US USD 105.32M 4.93M
Biocept BIOC:US USD 11.16M 4.54M
Bruker BRKR:US USD 507.6M 6.9M
Exact Sciences EXAS:US USD 661.13M 20.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Illumina ILMN:US USD 4.77B 3.03B
Immunogen IMGN:US USD 92.8M 17.59M
Intrexon XON:US USD 24.34M 2.74M
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Laboratory Of America LH:US USD 3.14B 34.3M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Myriad Genetics MYGN:US USD 201.4M 4.3M
Rigel Pharmaceuticals RIGL:US USD 40.81M 1.97M
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Sonic Healthcare SHL:AU AUD 3.64B 87.61M
Thermo Fisher Scientific TMO:US USD 8.97B 2M
Veracyte VCYT:US USD 85.27M 1.67M
Waters WAT:US USD 516.54M 1.86M